SG11201806812SA - Methods and systems for detection of abnormal karyotypes - Google Patents
Methods and systems for detection of abnormal karyotypesInfo
- Publication number
- SG11201806812SA SG11201806812SA SG11201806812SA SG11201806812SA SG11201806812SA SG 11201806812S A SG11201806812S A SG 11201806812SA SG 11201806812S A SG11201806812S A SG 11201806812SA SG 11201806812S A SG11201806812S A SG 11201806812SA SG 11201806812S A SG11201806812S A SG 11201806812SA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- tarrytown
- systems
- methods
- read coverage
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/10—Ploidy or copy number detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
- G16B30/10—Sequence alignment; Homology search
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/20—Supervised data analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Informatics (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Evolutionary Biology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Theoretical Computer Science (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Databases & Information Systems (AREA)
- Bioethics (AREA)
- Data Mining & Analysis (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Evolutionary Computation (AREA)
- Epidemiology (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Artificial Intelligence (AREA)
- Software Systems (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Management, Administration, Business Operations System, And Electronic Commerce (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662294669P | 2016-02-12 | 2016-02-12 | |
PCT/US2017/017734 WO2017139801A1 (en) | 2016-02-12 | 2017-02-13 | Methods and systems for detection of abnormal karyotypes |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201806812SA true SG11201806812SA (en) | 2018-09-27 |
Family
ID=58185625
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201806812SA SG11201806812SA (en) | 2016-02-12 | 2017-02-13 | Methods and systems for detection of abnormal karyotypes |
Country Status (13)
Country | Link |
---|---|
US (1) | US20170233806A1 (ja) |
EP (1) | EP3414691A1 (ja) |
JP (2) | JP6765433B2 (ja) |
KR (2) | KR102465122B1 (ja) |
CN (2) | CN109074426B (ja) |
AU (2) | AU2017218149B2 (ja) |
CA (1) | CA3014292A1 (ja) |
HK (1) | HK1259478A1 (ja) |
IL (2) | IL261216B (ja) |
MX (1) | MX2018009823A (ja) |
NZ (1) | NZ745249A (ja) |
SG (1) | SG11201806812SA (ja) |
WO (1) | WO2017139801A1 (ja) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10395759B2 (en) | 2015-05-18 | 2019-08-27 | Regeneron Pharmaceuticals, Inc. | Methods and systems for copy number variant detection |
US11608533B1 (en) * | 2017-08-21 | 2023-03-21 | The General Hospital Corporation | Compositions and methods for classifying tumors with microsatellite instability |
SG11202110655UA (en) * | 2019-03-28 | 2021-10-28 | Phase Genomics Inc | Systems and methods for karyotyping by sequencing |
CN112037174B (zh) * | 2020-08-05 | 2024-03-01 | 湖南自兴智慧医疗科技有限公司 | 染色体异常检测方法、装置、设备及计算机可读存储介质 |
US20220108773A1 (en) * | 2020-10-07 | 2022-04-07 | Baidu Usa Llc | Systems and methods for genome analysis and visualization |
CN112599189A (zh) * | 2020-12-29 | 2021-04-02 | 北京优迅医学检验实验室有限公司 | 一种全基因组测序的数据质量评估方法及其应用 |
CN112687336B (zh) * | 2021-03-11 | 2021-06-22 | 北京贝瑞和康生物技术有限公司 | 确定upd类型的方法、计算设备和存储介质 |
CN113113085B (zh) * | 2021-03-15 | 2022-08-19 | 杭州杰毅生物技术有限公司 | 基于智能宏基因组测序数据肿瘤检测的分析系统及方法 |
CN114049914B (zh) * | 2022-01-14 | 2022-04-15 | 苏州贝康医疗器械有限公司 | 一体化检测cnv、单亲二体、三倍体和roh的方法及装置 |
CN114743593B (zh) * | 2022-06-13 | 2023-02-24 | 北京橡鑫生物科技有限公司 | 一种基于尿液进行前列腺癌早期筛查模型的构建方法、筛查模型及试剂盒 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100216153A1 (en) * | 2004-02-27 | 2010-08-26 | Helicos Biosciences Corporation | Methods for detecting fetal nucleic acids and diagnosing fetal abnormalities |
US10017812B2 (en) * | 2010-05-18 | 2018-07-10 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US20140206552A1 (en) * | 2010-05-18 | 2014-07-24 | Natera, Inc. | Methods for preimplantation genetic diagnosis by sequencing |
US10643738B2 (en) * | 2013-01-10 | 2020-05-05 | The Chinese University Of Hong Kong | Noninvasive prenatal molecular karyotyping from maternal plasma |
WO2014165267A2 (en) * | 2013-03-12 | 2014-10-09 | Counsyl, Inc. | Systems and methods for prenatal genetic analysis |
US10385394B2 (en) * | 2013-03-15 | 2019-08-20 | The Translational Genomics Research Institute | Processes of identifying and characterizing X-linked disorders |
EP3149640B1 (en) * | 2014-05-30 | 2019-09-04 | Sequenom, Inc. | Chromosome representation determinations |
AU2015266665C1 (en) * | 2014-05-30 | 2021-12-23 | Verinata Health, Inc. | Detecting fetal sub-chromosomal aneuploidies and copy number variations |
DK3656875T3 (da) * | 2014-07-18 | 2021-12-13 | Illumina Inc | Ikke-invasiv prænatal diagnostik |
-
2017
- 2017-02-13 MX MX2018009823A patent/MX2018009823A/es unknown
- 2017-02-13 CA CA3014292A patent/CA3014292A1/en not_active Abandoned
- 2017-02-13 AU AU2017218149A patent/AU2017218149B2/en active Active
- 2017-02-13 US US15/431,715 patent/US20170233806A1/en active Pending
- 2017-02-13 KR KR1020217040618A patent/KR102465122B1/ko active IP Right Grant
- 2017-02-13 CN CN201780021833.8A patent/CN109074426B/zh active Active
- 2017-02-13 JP JP2018542281A patent/JP6765433B2/ja active Active
- 2017-02-13 SG SG11201806812SA patent/SG11201806812SA/en unknown
- 2017-02-13 CN CN202210809402.0A patent/CN115273970A/zh active Pending
- 2017-02-13 WO PCT/US2017/017734 patent/WO2017139801A1/en active Application Filing
- 2017-02-13 KR KR1020187026160A patent/KR102341129B1/ko active IP Right Grant
- 2017-02-13 NZ NZ745249A patent/NZ745249A/en unknown
- 2017-02-13 EP EP17707732.8A patent/EP3414691A1/en not_active Withdrawn
-
2018
- 2018-08-19 IL IL261216A patent/IL261216B/en unknown
-
2019
- 2019-02-01 HK HK19101887.3A patent/HK1259478A1/zh unknown
-
2020
- 2020-09-15 JP JP2020154436A patent/JP7144493B2/ja active Active
- 2020-09-30 AU AU2020244451A patent/AU2020244451B2/en active Active
-
2021
- 2021-10-26 IL IL287595A patent/IL287595A/en unknown
Also Published As
Publication number | Publication date |
---|---|
KR102341129B1 (ko) | 2021-12-21 |
EP3414691A1 (en) | 2018-12-19 |
IL261216B (en) | 2021-12-01 |
CN109074426A (zh) | 2018-12-21 |
AU2017218149B2 (en) | 2020-09-03 |
AU2017218149A1 (en) | 2018-09-06 |
CN115273970A (zh) | 2022-11-01 |
JP2019512122A (ja) | 2019-05-09 |
JP7144493B2 (ja) | 2022-09-29 |
US20170233806A1 (en) | 2017-08-17 |
AU2020244451B2 (en) | 2022-04-07 |
WO2017139801A1 (en) | 2017-08-17 |
CA3014292A1 (en) | 2017-08-17 |
NZ745249A (en) | 2021-07-30 |
KR20180116309A (ko) | 2018-10-24 |
JP2021019586A (ja) | 2021-02-18 |
KR102465122B1 (ko) | 2022-11-09 |
JP6765433B2 (ja) | 2020-10-07 |
KR20210154877A (ko) | 2021-12-21 |
IL287595A (en) | 2021-12-01 |
AU2020244451A1 (en) | 2020-10-29 |
MX2018009823A (es) | 2019-02-20 |
IL261216A (en) | 2018-10-31 |
CN109074426B (zh) | 2022-07-26 |
HK1259478A1 (zh) | 2019-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11201806812SA (en) | Methods and systems for detection of abnormal karyotypes | |
SG11201808261RA (en) | Genetic variant-phenotype analysis system and methods of use | |
SG11201910070PA (en) | Universal short adapters for indexing of polynucleotide samples | |
SG11201808144SA (en) | Computer systems and methods for creating asset-related tasks based on predictive models | |
SG11201806780PA (en) | Agent-based turing complete transactions integrating feedback within a blockchain system | |
SG11201908288XA (en) | Configurable annotations for privacy-sensitive user content | |
SG11201908489XA (en) | De novo synthesized combinatorial nucleic acid libraries | |
SG11201908890XA (en) | System and method for implementing different types of blockchain contracts | |
SG11201904942YA (en) | Blockchain-based service execution method and apparatus, and electronic device | |
SG11201805103VA (en) | Method and system for service enablement | |
SG11201809963XA (en) | Application framework using blockchain-based asset ownership | |
SG11201809649WA (en) | Macromolecule analysis employing nucleic acid encoding | |
SG11201909873TA (en) | Dynamic autonomous vehicle servicing and management | |
SG11201901668RA (en) | Detection of anomalies in multivariate data | |
SG11201808178VA (en) | Digital asset account management | |
SG11201808914UA (en) | Methods, systems and kits for in-pen assays | |
SG11201804957VA (en) | Neoantigen identification, manufacture, and use | |
SG11201803666WA (en) | Single image detection | |
SG11201909757RA (en) | Performing parallel execution of transactions in a distributed ledger system | |
SG11202000330XA (en) | Concept for generating an enhanced sound field description or a modified sound field description using a multi-point sound field description | |
SG11201810364VA (en) | Electronic mortgage brokering and monitoring | |
SG11201811025VA (en) | Systems and methods for automated annotation and screening of biological sequences | |
SG11201407609TA (en) | Systems and methods for calculating category proportions | |
SG11201900992XA (en) | Computer architecture and method for recommending asset repairs | |
SG11201906735RA (en) | Hydroxysteroid 17-beta dehydrogenase 13 (hsd17b13) variants and uses thereof |